Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center

This publication has 19 references indexed in Scilit:

• Multicenter in vitro comparative study of fluoroquinolones against 25,129 Gram-positive and Gram-negative clinical isolates
  Diagnostic Microbiology and Infectious Disease, 1995
• Epidemiology of Quinolone Resistance
  Drugs, 1995
• Epidemiology of Quinolone Resistance
  Drugs, 1995
• Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?
  Diagnostic Microbiology and Infectious Disease, 1994
• Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected β-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria
  Diagnostic Microbiology and Infectious Disease, 1994
• Prevalence of fluoroquinolone resistance in Europe
  Infection, 1994
• Susceptibility of clinical bacterial isolates to ciprofloxacin in the united states
  Infection, 1994
• Bacteremia due to fluoroquinolone-resistantEscherichia coli in two immunocompromised patients
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin: A 53-medical-center sample of spectra of activity
  Diagnostic Microbiology and Infectious Disease, 1994
• First clinical isolate of highly fluoroquinolone-resistantEscherichia coli in scandanavia
  European Journal of Clinical Microbiology & Infectious Diseases, 1990